rofecoxib has been researched along with Arthropathies in 3 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "To assess the efficiency of paracetamol, indicated in first instance for light-to-moderate pain from hip and knee arthrosis, against rofecoxib, the COX-2 inhibitor most commonly used in Spain." | 8.82 | [Analysis of cost-minimization treatment with paracetamol or COX-2 inhibitors (rofecoxib) for pain from arthrosis of the knee or hip]. ( Lizán Tudela, L; Magaz Marqués, S; Riesgo Bucher, Y; Varela Moreno, C, 2004) |
| "To assess the efficiency of paracetamol, indicated in first instance for light-to-moderate pain from hip and knee arthrosis, against rofecoxib, the COX-2 inhibitor most commonly used in Spain." | 4.82 | [Analysis of cost-minimization treatment with paracetamol or COX-2 inhibitors (rofecoxib) for pain from arthrosis of the knee or hip]. ( Lizán Tudela, L; Magaz Marqués, S; Riesgo Bucher, Y; Varela Moreno, C, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bragadóttir, G | 1 |
| Onundarson, PT | 1 |
| Ashley, ES | 1 |
| Kirk, K | 1 |
| Fowler, VG | 1 |
| Lizán Tudela, L | 1 |
| Magaz Marqués, S | 1 |
| Varela Moreno, C | 1 |
| Riesgo Bucher, Y | 1 |
1 review available for rofecoxib and Arthropathies
| Article | Year |
|---|---|
[Analysis of cost-minimization treatment with paracetamol or COX-2 inhibitors (rofecoxib) for pain from arthrosis of the knee or hip].
Topics: Acetaminophen; Analgesics, Non-Narcotic; Costs and Cost Analysis; Cyclooxygenase 2; Cyclooxygenase 2 | 2004 |
2 other studies available for rofecoxib and Arthropathies
| Article | Year |
|---|---|
Factor-sparing use of the COX-2 inhibitor rofecoxib in haemophilic arthropathy.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclo | 2002 |
Patient detection of a drug dispensing error by use of physician-provided drug samples.
Topics: Drug Prescriptions; Female; Humans; Joint Diseases; Lactones; Medication Errors; Middle Aged; Patien | 2002 |